Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : AMERICAN BIOMED, Minimally Invasive Technology (ABMI) -- Ignore unavailable to you. Want to Upgrade?

To: Bill Fortune III who wrote (408)	4/14/1998 10:31:00 AM
From: Bill Fortune III	Read Replies (1) \| Respond to of 2887

BRIGHT SPOTS Some Information found on Yahoo! "THE WALL STREET JOURNAL" Monday April 13, on page B13D. It talks about how some companies are under pressure in the Medical Supplies. NEW YORK -- Earnings at major medical-device companies were under pressure during the first quarter due to the strength of the dollar overseas and a lull at some companies between product cycles. Belt-tightening in Europe also had a damping effect on international sales growth. THERE WERE SOME BRIGHT SPOTS. The sector's most dramatic sales story continues to be coronary stents, tiny coil-like devices used to prop open blood vessels after a balloon angioplasty. NationsBanc Montgomery Securities Inc. projects U.S. sales will surge 50% in 1998 to about $1.2 billion. Stent sales should help drive earnings at market leaders Guidant Corp. and Arterial Vascular Engineering Inc.